References
- Text on Validation of Analytical Methods. Federal Register March, 1995; 60: 11260
- Wechsler J. Safety First—Washington Report. Pharm. Technol. 1998; 9: 16–28
- Streamling Induce NDA Updates, The Gold Sheet, F-D-C-Reports. 1999; 33, 1
- Nilsen C. L. Equipment calibration and maintenance. Pharm. Formul. Qual. 1999; 10: 41–42
- Wechsler J. FDA seeks regulatory relief in manufacturing and marketing policies—Washington Report. Pharm. Technol. 1999; 10: 16–26
- Immel B. Electronic records-An update. Pharm. Technol. 1999; 10: 64–72
- Boehlert J. P. Current analytical laboratory inspection trends. LC-GC 1997; 15(7)116–129
- Validation of Compendial Methods. U. S. Pharmacopeial Convention, Rockland, MD 1996; 3262, USP 23/NF 18. 4th Suppl.
- Quality Management And Assurance Standards, Part 3: guidelines for the application of ISO 9001:1994 to the development, installation and maintenance of systems. International Standards Organization. 1991
- International conference on harmonization for registration of Pharmaceuticals for human use, validation of analytical procedures methodology, Geneva, 1996
- Krull K., Swartz M. The international conference on harmonization—validation viewpoint. LC-GC 1999; 17(9)836–840
- Weichert E. Harmonizing the validation of analytical procedures. Biopharm 1999; 12(8)18–24
- Paino T. C, Moore A. D. Determination of the LOD and LOQ of an HPLC method using four different techniques. Pharm. Technol. 1999; 10: 86–90
- ANDAs: Impurities in Drug Products. CDER Draft Guidance. December, 1998
- Technical Information Package. Ranbaxy India Ltd., Data on file
- Guidelines for Submitting Samples and Analytical Data for Methods Validation. CDER Guidance. February, 1987